Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06287398
Status:
RECRUITING
Last Update Posted:
2024-03-01
First Post:
2024-02-07
Brief Title:
Epcoritamab Epcor-Containing Combination Salvage Therapy Followed by ASCT Epcor Consolidation in Patients With Relapsed LBCL
Sponsor:
Australasian Leukaemia and Lymphoma Group
Organization:
Australasian Leukaemia and Lymphoma Group
Organization Data
Organization:
Australasian Leukaemia and Lymphoma Group
Class:
OTHER
Study ID:
NHL38
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Australasian Leukaemia and Lymphoma Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None